A Study to Compare the Effects of Intrathecal Midazolam and Intrathecal Buprenorphine as Adjuvant to Levobupivacaine Heavy in Spinal Anaesthesia
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Prabuddha Bhave und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Intrathecal adjuvants are commonly added to local anaesthetics during spinal anaesthesia to improve block characteristics and prolong postoperative analgesia. Midazolam and buprenorphine are two such adjuvants with distinct mechanisms of action and analgesic profiles. The present study compared the efficacy and safety of intrathecal midazolam and intrathecal buprenorphine when used as adjuvants to hyperbaric levobupivacaine in patients undergoing infraumbilical surgeries.
Methods
This prospective interventional study was conducted in 60 patients aged 18–60 years with ASA physical status I or II undergoing elective infraumbilical surgeries under spinal anaesthesia. Patients were randomly allocated into two groups of 30 each. Group A received intrathecal midazolam 2 mg with 0.5% hyperbaric levobupivacaine, while Group B received intrathecal buprenorphine 120 µg with 0.5% hyperbaric levobupivacaine. Sensory and motor block characteristics, duration of postoperative analgesia, haemodynamic parameters, visual analogue scale (VAS) scores, sedation scores, and adverse effects were evaluated.
Results
Baseline demographic and clinical characteristics were comparable between the groups. Sensory onset was significantly faster in Group A (3.82 ± 0.93 min) than Group B (4.20 ± 1.58 min; p = 0.009). However, Group B demonstrated significantly prolonged two-segment sensory regression (210.83 ± 41.23 vs. 150.53 ± 32.82 min; p = 0.010), longer motor block duration (175.97 ± 40.23 vs. 143.33 ± 36.41 min; p = 0.033), and markedly prolonged postoperative analgesia (602.00 ± 128.99 vs. 307.67 ± 103.38 min; p = 0.005). VAS pain scores were significantly lower and Ramsay sedation scores significantly higher in Group B throughout the postoperative period. The incidence of hypotension, bradycardia, nausea, and vomiting was comparable between the groups.
Conclusion
Both intrathecal midazolam and buprenorphine were effective adjuvants to hyperbaric levobupivacaine for spinal anaesthesia. Midazolam provided a faster onset of sensory blockade, whereas buprenorphine produced significantly longer sensory and motor blockade, superior postoperative analgesia, and lower postoperative pain scores without increasing adverse effects. Intrathecal buprenorphine may therefore be the preferred adjuvant when prolonged postoperative analgesia is desired.
Zitieren
APA
Bhave, P., Singh, G., K., D. V., Vijayashree, S., & Indira, I. (2026). A Study to Compare the Effects of Intrathecal Midazolam and Intrathecal Buprenorphine as Adjuvant to Levobupivacaine Heavy in Spinal Anaesthesia. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.26
Vancouver
Bhave P, Singh G, K. DV, Vijayashree S, Indira I. A Study to Compare the Effects of Intrathecal Midazolam and Intrathecal Buprenorphine as Adjuvant to Levobupivacaine Heavy in Spinal Anaesthesia. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.26
BibTeX
@article{Bhave2026,
author = {Bhave, Prabuddha and Singh, Gajendra and K., Deepika V. and Vijayashree, Sai and Indira, Indira},
title = {A Study to Compare the Effects of Intrathecal Midazolam and Intrathecal Buprenorphine as Adjuvant to Levobupivacaine Heavy in Spinal Anaesthesia},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.26}
}
EUVIMED